The vaccination uses security versus the chikungunya infection, and will certainly currently be authorized or denied by the FDA by February 2025.
发布者:BY ANJA HAUGE,转转请注明出处:https://robotalks.cn/fda-grants-bavarian-nordic-vaccine-priority-review-status/